Bisphosphonates should be given to all postmenopausal women after primary breast cancer, but only 20% of CCGs are funding them
The UK’s biggest breast cancer charity is claiming that lives could be saved if more women were given a cheap drug that could potentially prevent the disease from returning.
Bisphosphonates, which cost around 43p a day, are used to strengthen the bones of women diagnosed with osteoporosis. But a review in 2015 showed that they can also reduce the number of breast cancers in postmenopausal women that spread within 10 years after treatment and recur in the bones, where they become incurable, from 8.8% to 6.6%.
This post was syndicated from Health | The Guardian. Click here to read the full text on the original website.